Edwards Lifesciences Corp
EW
Company Profile
Business description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Contact
One Edwards Way
IrvineCA92614
USAT: +1 949 250-2500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
15,800
Stocks News & Analysis
personal-finance
US stock market outlook: tariffs are 2025's wild card
Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,424.80 | 59.10 | 0.71% |
| CAC 40 | 7,593.87 | 38.00 | 0.50% |
| DAX 40 | 22,496.98 | 71.15 | 0.32% |
| Dow JONES (US) | 40,752.96 | 83.60 | 0.21% |
| FTSE 100 | 8,496.80 | 1.95 | 0.02% |
| HKSE | 22,411.22 | 291.81 | 1.32% |
| NASDAQ | 17,710.74 | 264.40 | 1.52% |
| Nikkei 225 | 36,705.53 | 253.23 | 0.69% |
| NZX 50 Index | 12,317.68 | 169.08 | 1.39% |
| S&P 500 | 5,604.14 | 35.08 | 0.63% |
| S&P/ASX 200 | 8,204.10 | 58.50 | 0.72% |
| SSE Composite Index | 3,279.03 | 7.62 | -0.23% |